143 related articles for article (PubMed ID: 38465940)
21. Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study.
Kiang MV; Chin ET; Huynh BQ; Chapman LAC; Rodríguez-Barraquer I; Greenhouse B; Rutherford GW; Bibbins-Domingo K; Havlir D; Basu S; Lo NC
Lancet Infect Dis; 2021 Jul; 21(7):929-938. PubMed ID: 33765417
[TBL] [Abstract][Full Text] [Related]
22. Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies.
Wong MP; Meas MA; Adams C; Hernandez S; Green V; Montoya M; Hirsch BM; Horton M; Quach HL; Quach DL; Shao X; Fedrigo I; Zermeno A; Huffaker J; Montes R; Madden A; Cyrus S; McDowell D; Williamson P; Contestable P; Stone M; Coloma J; Busch MP; Barcellos LF; Harris E
Microbiol Spectr; 2022 Jun; 10(3):e0247121. PubMed ID: 35612315
[TBL] [Abstract][Full Text] [Related]
23. Estimating incidence rates with misclassified disease status: a likelihood-based approach, with application to hepatitis C virus.
Shebl FM; El-Kamary SS; Shardell M; Langenberg P; Dorgham LS; Maguire JH; Magder LS
Int J Infect Dis; 2012 Jul; 16(7):e527-31. PubMed ID: 22543295
[TBL] [Abstract][Full Text] [Related]
24. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
[TBL] [Abstract][Full Text] [Related]
25. Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response.
Siegler AJ; Sullivan PS; Sanchez T; Lopman B; Fahimi M; Sailey C; Frankel M; Rothenberg R; Kelley CF; Bradley H
Ann Epidemiol; 2020 Sep; 49():50-60. PubMed ID: 32791199
[TBL] [Abstract][Full Text] [Related]
26. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
[TBL] [Abstract][Full Text] [Related]
27. A more reliable species richness estimator based on the Gamma-Poisson model.
Chiu CH
PeerJ; 2023; 11():e14540. PubMed ID: 36632143
[TBL] [Abstract][Full Text] [Related]
28. Inferencing superspreading potential using zero-truncated negative binomial model: exemplification with COVID-19.
Zhao S; Shen M; Musa SS; Guo Z; Ran J; Peng Z; Zhao Y; Chong MKC; He D; Wang MH
BMC Med Res Methodol; 2021 Feb; 21(1):30. PubMed ID: 33568100
[TBL] [Abstract][Full Text] [Related]
29. Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
Post LA; Benishay ET; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh LN; White J; Chaudhury AS; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Feb; 23(2):e25799. PubMed ID: 33475513
[TBL] [Abstract][Full Text] [Related]
30. Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis.
Stevenson M; Metry A; Messenger M
Health Technol Assess; 2021 Jun; 25(39):1-74. PubMed ID: 34142943
[TBL] [Abstract][Full Text] [Related]
31. Semiparametric estimation for nonparametric frailty models using nonparametric maximum likelihood approach.
Chee CS; Do Ha I; Seo B; Lee Y
Stat Methods Med Res; 2021 Nov; 30(11):2485-2502. PubMed ID: 34569366
[TBL] [Abstract][Full Text] [Related]
32. Efficiency of two-phase methods with focus on a planned population-based case-control study on air pollution and stroke.
Oudin A; Björk J; Strömberg U
Environ Health; 2007 Nov; 6():34. PubMed ID: 17988388
[TBL] [Abstract][Full Text] [Related]
33. Simulation-Based Estimation of SARS-CoV-2 Infections Associated With School Closures and Community-Based Nonpharmaceutical Interventions in Ontario, Canada.
Naimark D; Mishra S; Barrett K; Khan YA; Mac S; Ximenes R; Sander B
JAMA Netw Open; 2021 Mar; 4(3):e213793. PubMed ID: 33787909
[TBL] [Abstract][Full Text] [Related]
34. Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2.
Huisman JS; Scire J; Angst DC; Li J; Neher RA; Maathuis MH; Bonhoeffer S; Stadler T
Elife; 2022 Aug; 11():. PubMed ID: 35938911
[TBL] [Abstract][Full Text] [Related]
35. Trends and symptoms of SARS-CoV-2 infection: a longitudinal study on an Alpine population representative sample.
Barbieri G; Pizzato M; Gögele M; Giardiello D; Weichenberger CX; Foco L; Bottigliengo D; Bertelli C; Barin L; Lundin R; Pramstaller PP; Pattaro C; Melotti R
BMJ Open; 2023 Jun; 13(6):e072650. PubMed ID: 37290944
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of asymptomatic SARS-CoV-2 infection among individuals involved in academic research under limited operations during the COVID-19 pandemic.
Pettifor A; DiPrete BL; Shook-Sa BE; Premkumar L; Kuczynski K; Dittmer D; Aiello A; Wallet S; Maile R; Tan J; Jadi R; Pluta L; de Silva AM; Weber DJ; Kim M; Seña AC; Jones CD
PLoS One; 2022; 17(4):e0267353. PubMed ID: 35468150
[TBL] [Abstract][Full Text] [Related]
37. International travel-related control measures to contain the COVID-19 pandemic: a rapid review.
Burns J; Movsisyan A; Stratil JM; Biallas RL; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Klinger C; Kratzer S; Litwin T; Norris S; Pfadenhauer LM; von Philipsborn P; Sell K; Stadelmaier J; Verboom B; Voss S; Wabnitz K; Rehfuess E
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013717. PubMed ID: 33763851
[TBL] [Abstract][Full Text] [Related]
38. Using a network-based approach and targeted maximum likelihood estimation to evaluate the effect of adding pre-exposure prophylaxis to an ongoing test-and-treat trial.
Balzer L; Staples P; Onnela JP; DeGruttola V
Clin Trials; 2017 Apr; 14(2):201-210. PubMed ID: 28124579
[TBL] [Abstract][Full Text] [Related]
39. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
